Literature DB >> 12009302

Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants.

N Nunes-Tavares1, A Nery da Matta, C M Batista e Silva, G M N Araújo, S R W Louro, A Hassón-Voloch.   

Abstract

The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium. The antidepressants inhibited AChE activity by a non-competitive mechanism. Inhibition constants range from 200 to 400 microM. Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline. Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS). This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with K(D)=7 x 10(-7)M. It was observed that TCA drugs displaced propidium from the enzyme. On the basis of the displacement experiments antidepressant dissociation constants were determined. Similar values for the inhibition constants suggest that these drugs have similar affinity to the peripheral anionic site. The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants. These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009302     DOI: 10.1016/s1357-2725(02)00027-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  3 in total

1.  New therapeutic approaches and novel alternatives for organophosphate toxicity.

Authors:  Francine S Katz; Stevan Pecic; Laura Schneider; Zhengxiang Zhu; Ashley Hastings; Michal Luzac; Joanne Macdonald; Donald W Landry; Milan N Stojanovic
Journal:  Toxicol Lett       Date:  2018-03-31       Impact factor: 4.372

2.  Discovery of Helminthosporin, an Anthraquinone Isolated from Rumex abyssinicus Jacq as a Dual Cholinesterase Inhibitor.

Authors:  Ntemafack Augustin; Vijay K Nuthakki; Mohd Abdullaha; Qazi Parvaiz Hassan; Sumit G Gandhi; Sandip B Bharate
Journal:  ACS Omega       Date:  2020-01-13

3.  Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.

Authors:  Sandra Codony; Caterina Pont; Christian Griñán-Ferré; Ania Di Pede-Mattatelli; Carla Calvó-Tusell; Ferran Feixas; Sílvia Osuna; Júlia Jarné-Ferrer; Marina Naldi; Manuela Bartolini; María Isabel Loza; José Brea; Belén Pérez; Clara Bartra; Coral Sanfeliu; Jordi Juárez-Jiménez; Christophe Morisseau; Bruce D Hammock; Mercè Pallàs; Santiago Vázquez; Diego Muñoz-Torrero
Journal:  J Med Chem       Date:  2022-03-10       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.